Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: Masked hypertension and elevated nighttime BP are associated with increased risk of hypertensive target organ damage and adverse cardiovascular and renal outcomes in patients with normal kidney function. The significance of masked hypertension for these risks in patients with CKD is less well defined. The objective of this study was to evaluate the association between masked hypertension and kidney function and markers of cardiovascular target organ damage, and to determine whether this relationship was consistent among those with and without elevated nighttime BP. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a cross-sectional study. We performed 24-hour ambulatory BP in 1492 men and women with CKD enrolled in the Chronic Renal Insufficiency Cohort Study. We categorized participants into controlled BP, white-coat, masked, and sustained hypertension on the basis of clinic and 24-hour ambulatory BP. We obtained echocardiograms and measured pulse wave velocity in 1278 and 1394 participants, respectively. RESULTS: The percentages of participants with controlled BP, white-coat, masked, and sustained hypertension were 49.3%, 4.1%, 27.8%, and 18.8%, respectively. Compared with controlled BP, masked hypertension independently associated with low eGFR (-3.2 ml/min per 1.73 m(2); 95% confidence interval, -5.5 to -0.9), higher proteinuria (+0.9 unit higher in log2 urine protein; 95% confidence interval, 0.7 to 1.1), and higher left ventricular mass index (+2.52 g/m(2.7); 95% confidence interval, 0.9 to 4.1), and pulse wave velocity (+0.92 m/s; 95% confidence interval, 0.5 to 1.3). Participants with masked hypertension had lower eGFR only in the presence of elevated nighttime BP (-3.6 ml/min per 1.73 m(2); 95% confidence interval, -6.1 to -1.1; versus -1.4 ml/min per 1.73 m(2); 95% confidence interval, -6.9 to 4.0, among those with nighttime BP <120/70 mmHg; P value for interaction with nighttime systolic BP 0.002). CONCLUSIONS: Masked hypertension is common in patients with CKD and associated with lower eGFR, proteinuria, and cardiovascular target organ damage. In patients with CKD, ambulatory BP characterizes the relationship between BP and target organ damage better than BP measured in the clinic alone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A lower eGFR is associated with resistant hypertension, masked hypertension, and elevated nighttime BP values. 92”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hypertension is a major risk factor for the development and progression of albuminuria and any form of CKD. 92”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [92]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Chobanian, A. V., Bakris, G. L., Black, H. R., Cushman, W. C., Green, L. A., Izzo, J. L., Jones, D. W., Materson, B. J., Oparil, S., Wright, J. T., et al. (2003) · Hypertension · doi:10.1161/01.hyp.0000107251.49515.c2 · Cited by 13,271
Self-citationLang, R. M., Bierig, M., Devereux, R. B., Flachskampf, F. A., Foster, E., Pellikka, P. A., Picard, M. H., Roman, M. J., Seward, J., Shanewise, J. S., et al. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.10.005 · Cited by 11,318
O'Brien, E., Asmar, R., Beilin, L., Imai, Y., Mallion, J.-M., Mancia, G., Mengden, T., Myers, M., Padfield, P., Palatini, P., et al. (2003) · Journal of Hypertension · doi:10.1097/00004872-200305000-00001 · Cited by 1,655
Vlachopoulos, C., Aznaouridis, K., O'Rourke, M. F., Safar, M. E., Baou, K., & Stefanadis, C. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq024 · Cited by 1,363
Bobrie, G. (2004) · JAMA · doi:10.1001/jama.291.11.1342 · Cited by 842
Impact of left ventricular hypertrophy on survival in end-stage renal disease
Silberberg, J. S., Barre, P. E., Prichard, S. S., & Sniderman, A. D. (1989) · Kidney International · doi:10.1038/ki.1989.192 · Cited by 784
The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods
Feldman, H. I., Appel, L. J., Chertow, G. M., Cifelli, D., Cizman, B., Daugirdas, J., Fink, J. C., Franklin-Becker, E. D., Go, A. S., Hamm, L. L., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000070149.78399.ce · Cited by 659
Self-citationLash, J. P., Go, A. S., Appel, L. J., He, J., Ojo, A., Rahman, M., Townsend, R. R., Xie, D., Cifelli, D., Cohan, J., et al. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.00070109 · Cited by 619
Self-citationAortic pulse wave velocity index and mortality in end-stage renal disease
Blacher, J., Safar, M. E., Guerin, A. P., Pannier, B., Marchais, S. J., & London, G. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00932.x · Cited by 532
Cited by
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Self-citation2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
“• Hypertension is a major risk factor for the development and progression of albuminuria and any form of CKD.”
InfluentialMancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001940 · Cited by 2,885
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
McEvoy, J. W., McCarthy, C. P., Bruno, R. M., Brouwers, S., Canavan, M. D., Ceconi, C., Christodorescu, R. M., Daskalopoulou, S. S., Ferro, C. J., Gerdts, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae178 · Cited by 2,298
The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019)
Umemura, S., Arima, H., Arima, S., Asayama, K., Dohi, Y., Hirooka, Y., Horio, T., Hoshide, S., Ikeda, S., Ishimitsu, T., et al. (2019) · Hypertension Research · doi:10.1038/s41440-019-0284-9 · Cited by 1,880
2020 International Society of Hypertension global hypertension practice guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002453 · Cited by 1,283
“The same treatment strategy can be applied to patients with HFpEF even if the optimal treatment strategy is not known.91 Hypertension and Chronic Kidney Disease (CKD) • Hypertension is a major risk factor for the development and progression of albuminuria and any form of CKD.92 • A lower eGFR is associated with resist…”
InfluentialWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Circulation · doi:10.1161/cir.0000000000000596 · Cited by 1,127
Self-citationHypertension as Cardiovascular Risk Factor in Chronic Kidney Disease
Burnier, M., & Damianaki, A. (2023) · Circulation Research · doi:10.1161/circresaha.122.321762 · Cited by 400
“141 In the future, these prominent therapies might prove to be safe and efficient not only for lowering BP but also for preventing target end-organ damage, especially for patients with high cardiovascular burden like patients with CKD.”
InfluentialHypertension in Chronic Kidney Disease
Hamrahian, S. M., & Falkner, B. (2016) · Advances in Experimental Medicine and Biology · doi:10.1007/5584_2016_84 · Cited by 246
Hypertension management in patients with cardiovascular comorbidities
Lauder, L., Mahfoud, F., Azizi, M., Bhatt, D. L., Ewen, S., Kario, K., Parati, G., Rossignol, P., Schlaich, M. P., Teo, K. K., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehac395 · Cited by 210
Self-citationDrawz, P. E., Pajewski, N. M., Bates, J. T., Bello, N. A., Cushman, W. C., Dwyer, J. P., Fine, L. J., Goff, D. C., Haley, W. E., Krousel-Wood, M., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.116.08076 · Cited by 170
Self-citationBlood Pressure Measurement and Treatment Decisions: Masked and White-Coat Hypertension
Kario, K., Thijs, L., & Staessen, J. A. (2019) · Circulation Research · doi:10.1161/circresaha.118.313219 · Cited by 110
Blood Pressure and Cardiorenal Outcomes With Finerenone in Chronic Kidney Disease in Type 2 Diabetes
Ruilope, L. M., Agarwal, R., Anker, S. D., Filippatos, G. S., Pitt, B., Rossing, P. R., Sarafidis, P. A., Schmieder, R. E., Joseph, A., Rethemeier, N., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19744 · Cited by 119
Arterial Stiffness in CKD: A Review
Townsend, R. R. (2018) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2018.04.005 · Cited by 115
Self-citationCircadian clocks of the kidney: function, mechanism, and regulation
Costello, H. M., Johnston, J. G., Juffre, A., Crislip, G. R., & Gumz, M. L. (2022) · Physiological Reviews · doi:10.1152/physrev.00045.2021 · Cited by 136
Masked hypertension: understanding its complexity
Franklin, S. S., O'Brien, E. T., & Staessen, J. A. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw502 · Cited by 114
Gumz, M. L., Shimbo, D., Abdalla, M., Balijepalli, R. C., Benedict, C., Chen, Y., Earnest, D. J., Gamble, K. L., Garrison, S., Gong, M. C., et al. (2022) · Hypertension · doi:10.1161/hypertensionaha.122.19372 · Cited by 112
Self-citationMasked hypertension and cardiovascular outcomes: an updated systematic review and meta-analysis
Palla, M., Saber, H., Konda, S., & Briasoulis, A. (2018) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s128947 · Cited by 88
Borrelli, S., Garofalo, C., Gabbai, F. B., Chiodini, P., Signoriello, S., Paoletti, E., Ravera, M., Bussalino, E., Bellizzi, V., Liberti, M. E., et al. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.04.010 · Cited by 87
Rahman, M., Wang, X., Bundy, J. D., Charleston, J. B., Cohen, D. L., Cohen, J. B., Drawz, P. E., Ghazi, L., Horowitz, E. A., Lash, J. P., et al. (2020) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020030236 · Cited by 78
Self-citationBlood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients
Mallamaci, F., Tripepi, G. L., D’Arrigo, G., Borrelli, S., Garofalo, C., Stanzione, G., Provenzano, M., Nicola, L. D., Conte, G., Minutolo, R., et al. (2019) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04030318 · Cited by 65
Ambulatory Blood Pressure in Chronic Kidney Disease: Ready for Prime Time?
Velasquez, M. T., Beddhu, S., Nobakht, E., Rahman, M., & Raj, D. S. (2016) · Kidney International Reports · doi:10.1016/j.ekir.2016.05.001 · Cited by 62
Self-citationImplementing Home Blood Pressure Monitoring into Clinical Practice
Liyanage-Don, N. A., Fung, D., Phillips, E., & Kronish, I. M. (2019) · Current Hypertension Reports · doi:10.1007/s11906-019-0916-0 · Cited by 65
An Update on Masked Hypertension
Anstey, D. E., Pugliese, D. N., Abdalla, M., Bello, N. A., Givens, R. C., & Shimbo, D. (2017) · Current Hypertension Reports · doi:10.1007/s11906-017-0792-4 · Cited by 58
Drawz, P. E., Beddhu, S., Bignall, O. N. R., Cohen, J. B., Flynn, J. T., Ku, E., Rahman, M., Thomas, G., Weir, M. R., & Whelton, P. K. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.09.013 · Cited by 57
Self-citationDrawz, P. E., Brown, R. Z., Nicola, L. D., Fujii, N., Gabbai, F. B., Gassman, J., He, J., Iimuro, S., Lash, J. P., Minutolo, R., et al. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.13181117 · Cited by 48
Self-citationDisease burden of chronic kidney disease due to hypertension from 1990 to 2019: a global analysis
Chen, A., Zou, M., Young, C. A., Zhu, W., Chiu, H.-C., Jin, G., & Tian, L. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.690487 · Cited by 42
Management of traditional risk factors for the development and progression of chronic kidney disease
Lo, R. H., Narasaki, Y., Lei, S., & Rhee, C. M. (2023) · Clinical Kidney Journal · doi:10.1093/ckj/sfad101 · Cited by 45
“%) and another study in CKD patients showing a prevalence of 27.8% [13, 14].”
BackgroundInfluentialComorbidity of patients with noncommunicable diseases in general practice. Eurasian guidelines
Drapkina, O. M., Васильевна, К. А., Калинина, А. М., Avdeev, S. N., Викторович, А. М., Алексеева, Л. И., Almazova, I. I., Andreenko, Е. Y., Antipushina, D. N., Balanova, Y. А., et al. (2024) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2024-3996 · Cited by 65
BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols
Drawz, P. E., & Ix, J. H. (2018) · Journal of the American Society of Nephrology · doi:10.1681/asn.2017070753 · Cited by 40
Self-citationNocturnal Systolic Hypertension and Adverse Prognosis in Patients with CKD
Wang, Q., Wang, Y., Wang, J., Zhang, L., Zhao, M., & (C-STRIDE), T. C. C. S. O. C. K. D. (2021) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.14420920 · Cited by 42
Schneider, M. P., Hilgers, K. F., Schmid, M. C., Hübner, S., Nadal, J., Seitz, D., Busch, M., Haller, H. G., Köttgen, A., Kronenberg, F., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202604 · Cited by 45
“…only 4.1% of patients had controlled 24-hour ambulatory blood pressure but uncontrolled office blood pressure, i.e. “white-coat” hypertension, whereas no fewer than 27.8% exhibited “masked” hypertension, i.e. uncontrolled ambulatory blood pressure despite controlled office blood pressure [35].”
BackgroundInfluentialBlood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease
Scheppach, J. B., Raff, U., Toncar, S., Ritter, C. O., Klink, T., Störk, S., Wanner, C., Schlieper, G., Saritas, T., Reinartz, S. D., et al. (2018) · Hypertension · doi:10.1161/hypertensionaha.118.11608 · Cited by 42
Hsu, C., Lu, P., Lo, M., Lin, I.-C., & Tain, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215301 · Cited by 40
“Like PWV, the AASI is an indirect arterial stiffness index [33].”
BackgroundSelf-citationBlood Pressure Measurement: A KDOQI Perspective
Drawz, P. E., Beddhu, S., Kramer, H., Rakotz, M., Rocco, M. V., & Whelton, P. K. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.08.030 · Cited by 44
Self-citationBurnier, M., Kreutz, R. H., Narkiewicz, K., Kjeldsen, S. E., Oparil, S., & Mancia, G. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002532 · Cited by 50
Xie, Z., Zhang, J., Wang, C., & Yan, X. (2021) · BMC Cardiovascular Disorders · doi:10.1186/s12872-021-02081-8 · Cited by 37
“Additionally, with the introduction of ambulatory blood pressure monitoring (ABPM) into regular hypertension management, daynight patterns of blood pressure can be observed [3].”
BackgroundKDOQI US Commentary on the 2017 ACC/AHA Hypertension Guideline
Kramer, H., Townsend, R. R., Griffin, K. A., Flynn, J. T., Weiner, D. E., Rocco, M. V., Choi, M. J., Weir, M. R., Chang, T. I., Agarwal, R., et al. (2019) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2019.01.007 · Cited by 38
Self-citationIntegrating Out-of-Office Blood Pressure in the Diagnosis and Management of Hypertension
Cohen, J. B., & Cohen, D. L. (2016) · Current Cardiology Reports · doi:10.1007/s11886-016-0780-3 · Cited by 39
Guidelines for the management of hypertension in CKD patients: where do we stand in 2024?
Theodorakopoulou, M. P., Ortíz, A., Fernández‐Fernández, B., Kanbay, M., Minutolo, R., & Sarafidis, P. A. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae278 · Cited by 56
“…high BP CKD, due to the increased prevalence of specific phenotypes ( i.e. masked hypertension and nocturnal hypertension, abnormal dipping status) [9 , 17 –19 ] that apply as specific indications for HBPM and ABPM, respectively [Class of Recommendation ( CoR) I, Level of Evidence ( LoE) B] [14 ].”
Association of Arterial Stiffness With Chronic Kidney Disease Progression and Mortality
Voicehovska, J., Bormane, E., Grigane, A., Moisejevs, G., Moreino, E., Trumpika, D., & Voicehovskis, V. (2021) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.08.011 · Cited by 39
Fu, X., Ren, H., Xie, J., Wang, W., Li, Y., Gao, P., & Chen, N. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.14460 · Cited by 36
Hypertension in Chronic Kidney Disease: An Update on Diagnosis and Management
Gupta, A., Nagaraju, S. P., Bhojaraja, M. V., Swaminathan, S. M., & Mohan, P. B. (2023) · Southern Medical Journal · doi:10.14423/smj.0000000000001516 · Cited by 33
Sarafidis, P. A., Schmieder, R. E., Burnier, M., Persu, A., Januszewicz, A., Halimi, J., Arıcı, M., Ortíz, A., Wanner, C., Mancia, G., et al. (2024) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfae041 · Cited by 36
“However, the guidelines highlight the increased prevalence of masked hypertension and high night-time BP with abnormal dipping status in patients with CKD [10 –13 ] as specific indications for HBPM and ABPM, respectively, in these individuals (CoR I, LoE B) [1 ].”
BackgroundMallamaci, F., Tripepi, R., D’Arrigo, G., Porto, G., Versace, M. C., Marino, C., Sanguedolce, M. C., Testa, A., Tripepi, G. L., & Zoccali, C. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfy355 · Cited by 32
Hypertension after Kidney Transplantation: Clinical Significance and Therapeutical Aspects
Andreevska, G. S., Danilovska, I., Sikole, A., Popov, Z., & Ivanovski, N. (2019) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2019.264 · Cited by 31
“Despite the fact that kidney transplantation reduces the risk of both, cardiovascular morbidity and mortality remain a leading cause of death with functioning graft among kidney transplant recipients (KTR) [1], [2], [3], [4] Among the traditional and non-traditional risk factors, post-transplant hypertension (PTxH) re…”
BackgroundPrediction of Masked Hypertension and Masked Uncontrolled Hypertension Using Machine Learning
Hung, M.-H., Shih, L.-C., Wang, Y.-C., Leu, H., Huang, P., Wu, T.-C., Lin, S., Pan, W., Chen, J., & Huang, C. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.778306 · Cited by 35
Self-citationMasked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events
Babu, M., & Drawz, P. E. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1154-4 · Cited by 35
Self-citationBlood Pressure and Chronic Kidney Disease Progression: An Updated Review
Habas, E. M., Habas, E., Khan, F. Y., Rayani, A., Habas, A., Errayes, M., Farfar, K. L., & Elzouki, A.-N. Y. (2022) · Cureus · doi:10.7759/cureus.24244 · Cited by 46
“There is substantial evidence to indicate that CKD is strongly linked to uncontrolled high BP, resistant HTN, masked HTN, and even normotensive non-dipping BP records [21].”
BackgroundNocturnal blood pressure patterns and cardiovascular outcomes in patients with masked hypertension
Presta, V., Figliuzzi, I., D’Agostino, M., Citoni, B., Miceli, F., Simonelli, F., Coluccia, R., Musumeci, B., Ferrucci, A., Volpe, M., et al. (2018) · Journal of Clinical Hypertension · doi:10.1111/jch.13361 · Cited by 27
Buhnerkempe, M., Prakash, V., Botchway, A., Adekola, B., Cohen, J. B., Rahman, M., Weir, M. R., Ricardo, A. C., & Flack, J. M. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15064 · Cited by 27
Self-citationMasked hypertension and kidney function decline: the Jackson Heart Study
Mwasongwe, S. E., Min, Y., Booth, J. N., Katz, R., Sims, M., Correa, A., Young, B. A., & Muntner, P. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001727 · Cited by 27
“However, the effect of masked hypertension on the risk for CKD is less clear as prior studies have been cross-sectional or were conducted among people with established CKD [5,14,15].”
BP Measurement Techniques: What They Mean for Patients with Kidney Disease
Thomas, G., & Drawz, P. E. (2018) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.12551117 · Cited by 27
Self-citationThe roles of sodium and volume overload on hypertension in chronic kidney disease
Shin, J., & Lee, C. H. (2021) · Kidney Research and Clinical Practice · doi:10.23876/j.krcp.21.800 · Cited by 32
“The association of MH and lower eGFR was observed only in patients with increased nighttime BP even though the mechanisms of increased MH in CKD are multifactorial [35].”
BackgroundAnnual deterioration of renal function in hypertensive patients with and without diabetes
Polónia, J. J., Azevedo, A. C., Monte, M., da Silva, J. I. B. S., & Bertoquini, S. (2017) · Vascular Health and Risk Management · doi:10.2147/vhrm.s135253 · Cited by 28
Ghazi, L., Pajewski, N. M., Rifkin, D. E., Bates, J. T., Chang, T. I., Cushman, W. C., Glasser, S. P., Haley, W. E., Johnson, K., Kostis, W. J., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011706 · Cited by 23
Self-citationMasked Uncontrolled Hypertension Is Accompanied by Increased Out-of-Clinic Aldosterone Secretion
Siddiqui, M., Judd, E. K., Zhang, B., Dudenbostel, T., Carey, R. M., Oparil, S., & Calhoun, D. A. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15950 · Cited by 21
Ghazi, L., COHEN, L. P., Muntner, P., Shimbo, D., & Drawz, P. E. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15300 · Cited by 23
Self-citationZuo, J., Hu, Y., Chang, G., Chu, S., Tan, I., Butlin, M., & Avolio, A. P. (2019) · Journal of Human Hypertension · doi:10.1038/s41371-019-0275-y · Cited by 24
Albuminuria and masked uncontrolled hypertension in chronic kidney disease
Agarwal, R. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw325 · Cited by 22
“Furthermore, MUCH is also associated with lower estimated glomerular filtration rate (eGFR) and greater proteinuria [3, 4, 6, 7].”
BackgroundResultInfluentialGorbunov, V. M., Смирнова, М. И., Kurekhyan, A. S., & Drapkina, O. M. (2023) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2023-3666 · Cited by 23
Masked Uncontrolled Hypertension Is Not Attributable to Medication Nonadherence
Siddiqui, M., Judd, E. K., Dudenbostel, T., Zhang, B., Gupta, P., Tomaszewski, M., Patel, P., Oparil, S., & Calhoun, D. A. (2019) · Hypertension · doi:10.1161/hypertensionaha.119.13258 · Cited by 20
Tai, Y., Saeki, K., Yamagami, Y., Yoshimoto, K., Kurumatani, N., Nishio, K., & Obayashi, K. (2019) · Chronobiology International · doi:10.1080/07420528.2019.1675685 · Cited by 19
“Some risk factors increasing night- and sleep-time BP are suggested, such as diabetes, chronic kidney disease, and sleep disordered breathing; however, environmental factors are yet to be entirely elucidated (Ayala et al. 2013; Drawz et al. 2016; Ejaz et al. 2004; Kario et al. 1998; Parati et al. 2014; Saeki et al. 20…”
BackgroundNew Insights on Chronotherapy in Hypertension: Is Timing Everything?
Thoonkuzhy, C., & Rahman, M. (2020) · Current Hypertension Reports · doi:10.1007/s11906-020-1032-x · Cited by 21
Self-citationGhazi, L., Yaffe, K. S., Tamura, M. K., Rahman, M., Hsu, C., Anderson, A. H., Cohen, J. B., Fischer, M. J., Miller, E. R., Navaneethan, S. D., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.10570919 · Cited by 19
Self-citationPolychronopoulou, E., Wuerzner, G., & Burnier, M. (2021) · Vascular Health and Risk Management · doi:10.2147/vhrm.s292522 · Cited by 26
“Both nocturnal and resistant hypertension are associated with an increased risk of cardiovascular events.(18,19) The practical implication of these two observations is that out-of-office BP measurements providing both daytime and nighttime BP values should be performed more regularly in patients with hypertension and…”
BackgroundHypertension in Chronic Kidney Disease: Novel Insights
Duni, Α., Dounousi, E. C., Pavlakou, P., Eleftheriadis, T., & Liakopoulos, V. (2019) · Current Hypertension Reviews · doi:10.2174/1573402115666190415153554 · Cited by 18
Lv, Q., Wang, Y., Li, Y., Zhao, L., Gong, Y., Wang, M., Wang, M., Fu, G., & Zhang, W. (2020) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000828 · Cited by 17
Optimal blood pressure target and measurement in patients with chronic kidney disease
Kim, C. S., Choi, H. S., Bae, E. H., Kim, S. W., & Kwon, S. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.164 · Cited by 19
“Previous studies have shown that low eGFR and proteinuria are associated with nighttime and masked hypertension [25-27].”
The Association of Orthostatic Hypotension With Ambulatory Blood Pressure Phenotypes in SPRINT
Ghazi, L., Drawz, P. E., Pajewski, N. M., & Juraschek, S. P. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpaa184 · Cited by 16
Self-citationLi, X., Lian, R., Zhu, Y., Ke, J., Li, M., Wang, C., & Lou, T. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002461 · Cited by 16
“Further adjustment for other risk factors [30] and clinic SBP, the correlation between mSBP and LVH, and abnormal CIMT still reached statistical significance, whereas there was no significant association between mSBP and impaired renal function.”
BackgroundImplementing a home-based virtual hypertension programme—a pilot feasibility study
Gupta, A., Ellis, S. D., Burkhardt, C. D., Young, K. J., Mazzotti, D. R., Mahnken, J. D., Abu-el-rub, N., Chandaka, S., Comfort, B. W., Shanks, D., et al. (2022) · Family Practice · doi:10.1093/fampra/cmac084 · Cited by 17
Damianaki, A., Polychronopoulou, E., Wuerzner, G., & Burnier, M. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00495-1 · Cited by 20
Discrepancies in Clinic and Ambulatory Blood Pressure in Korean Chronic Kidney Disease Patients
Oh, Y. K., Chin, H. J., Ahn, S. Y., An, J. N., Lee, J. P., Lim, C. S., & Oh, K. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.5.772 · Cited by 14
“Previous studies of CKD cohorts showed that masked HT was associated with low eGFR, elevated urine protein excretion, high er left ventricular hypertrophy and higher pulse wave velocity (10,14,18,19).”
BackgroundKu, E., Hsu, R. K., Tuot, D. S., Bae, S. R., Lipkowitz, M. S., Smogorzewski, M. J., Grimes, B. A., & Weir, M. R. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.011013 · Cited by 15
Self-citationMasked arterial hypertension: prevalence, pathophysiological determinants and clinical significance
Гельцер, Б. И., Kotelnikov, V. N., Vetrova, О. О., & Karpov, R. S. (2019) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2019-9-92-98 · Cited by 16
Cho, S. M. J., Lee, H., Yoo, T., Jhee, J. H., Park, S., & Kim, H. C. (2021) · American Journal of Hypertension · doi:10.1093/ajh/hpab031 · Cited by 21
Sible, I. J., & Nation, D. A. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.35 · Cited by 15
“As previously reported (21), a subset of SPRINT participants (897/9361) underwent 24-hour ambulatory BP monitoring using SpaceLabs Medical Model 90207 monitors and standard collection protocol (29–32) within 3 weeks of the 27-month follow-up visit.”
BackgroundMwasongwe, S. E., Tanner, R. M., Poudel, B., Pugliese, D. N., Young, B. A., Abdalla, M., Musani, S. K., Gutiérrez, O. M., Correa, A., Shimbo, D., et al. (2020) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08840719 · Cited by 13
Mandava, S., Vinta, S. R., Ghosh, H., & Rahat, I. S. (2024) · EAI Endorsed Transactions on Internet of Things · doi:10.4108/eetiot.5325 · Cited by 12
“Chronic Kidney Disease (CKD) often correlates with hypertension, or high blood pressure, as per the National Kidney Foundation, where hypertension is both a cause and an outcome of CKD [13].”
BackgroundMotiejūnaitė, J., Flamant, M., Arnoult, F., Lahens, A., Tabibzadeh, N., Boutten, A., Rouzet, F., Vrtovsnik, F., Vidal‐Petiot, E., & de Pinho, N. A. (2024) · Hypertension Research · doi:10.1038/s41440-024-01778-5 · Cited by 14
“Studies of the association between albuminuria and BP pro fi les have shown that elevated ACR is a predictor of elevated nighttime BP [19].”
Jaques, D. A., Müller, H., Martinez, C., de Seigneux, S., Martin, P., Ponte, B., & Saudan, P. (2018) · Blood Pressure Monitoring · doi:10.1097/mbp.0000000000000337 · Cited by 12
Chen, W., Wu, S. V., Sun, J.-H., Tai, C., Lee, M., & Chu, C.-H. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19148488 · Cited by 15
Masked Hypertension: Lessons for the Future.
Penmatsa, K. R., Biyani, M., & Gupta, A. (2020) · PubMed Central · Cited by 11
af Geijerstam, P., Engvall, J. E., Östgren, C. J., Rådholm, K., & Nyström, F. H. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003431 · Cited by 11
Tocci, G., Citoni, B., Nardoianni, G., Figliuzzi, I., & Volpe, M. (2022) · Internal and Emergency Medicine · doi:10.1007/s11739-022-02961-7 · Cited by 13
“1 3 in large epidemiological surveys and observational clinical studies in hypertension performed during the last few years [30, 36, 39, 40].”
BackgroundGluskin, E., Tzukert, K., Levi, I. M.-Y., Gotsman, O., Sagiv, I., Abel, R., Bloch, A., Rubinger, D., Aharon, M., Elhalel, M. D., et al. (2019) · BMC Nephrology · doi:10.1186/s12882-019-1442-7 · Cited by 13
Nolde, J. M., Kiuchi, M. G., Carnagarin, R., Frost, S. M., Kannenkeril, D., Lugo‐Gavidia, L. M., Chan, J., Joyson, A., Matthews, V. B., Herat, L. Y., et al. (2020) · Journal of Clinical Hypertension · doi:10.1111/jch.14114 · Cited by 9
Wen, R., Chen, X.-Q., Zhu, Y., Ke, J., Du, Y., Wang, C., & Lou, T. (2020) · BMC Nephrology · doi:10.1186/s12882-020-02200-1 · Cited by 12
Spoto, B., Ntounousi, E., Testa, A., Liakopoulos, V., D’Arrigo, G., Tripepi, G. L., Parlongo, R. M., Sanguedolce, M. C., Mallamaci, F., & Zoccali, C. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001746 · Cited by 11
Mejia-Vilet, J. M., López-Hernández, Y. J., Matos, M. T., Santander-Velez, J. I., Cano‐Verduzco, M. L., Cruz, C., & Morales-Buenrostro, L. E. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04830-9 · Cited by 10
Wang, Q., Wang, Y., Wang, J., Zhang, L., Zhao, M., (C-STRIDE), T. C. C. S. O. C. K. D., Zhao, M., Zhang, L., Wang, X., Yuan, J., et al. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02413-w · Cited by 12
“1% in the Chronic Renal Insufficiency Cohort (CRIC) Study [4] and 5.”
BackgroundInfluentialEşme, M., Doğu, B. B., Yavuz, B., Asıl, S., Doğrul, R. T., Sümer, F., Kılıç, M. K., Kızılarslanoğlu, M. C., Varan, H. D., Sağır, A., et al. (2017) · The Journals of Gerontology Series A · doi:10.1093/gerona/glx150 · Cited by 12
Ma, J., Wang, J., Ying, J., Xie, S., Su, Q., Zhou, T., Han, F., Xu, J., Zhu, S., Yuan, C., et al. (2024) · Journal of Medical Internet Research · doi:10.2196/54206 · Cited by 16
Zhang, W., Redline, S. S., Viswanathan, A., Ascher, S. B., Hari, D., Juraschek, S. P., Tzourio, C., Drawz, P. E., Lipsitz, L. A., Mittleman, M. A., et al. (2025) · Hypertension · doi:10.1161/hypertensionaha.124.24222 · Cited by 10
Self-citationNagaraju, S. P., Shenoy, S. V., Rao, I. R., Bhojaraja, M. V., Rangaswamy, D., & Prabhu, R. A. (2022) · International Journal of Nephrology and Renovascular Disease · doi:10.2147/ijnrd.s343582 · Cited by 9
“Similar to ABPM, HBPM also aids in the diagnosis of various BP phenotypes such as “white-coat” hypertension, masked (reverse white-coat) hypertension, the “white-coat” effect, and masked uncontrolled which are highly prevalent in CKD patients.(42,43) ABPM remains the gold standard for the diagnosis and management of h…”
BackgroundResultGhazi, L., Cohen, J. B., Townsend, R. R., Drawz, P. E., Rahman, M., Pradhan, N., Cohen, D. L., Weir, M. R., Rincon-Choles, H., & Juraschek, S. P. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003604 · Cited by 9
Self-citation
Metadata
- Authors
- Drawz, P. E., Alper, A. B., Anderson, A. H., Brecklin, C. S., Charleston, J., Chen, J., Deo, R., Fischer, M. J., He, J., Hsu, C.-Y., Huan, Y., Keane, M. G., Kusek, J. W., Makos, G. K., Miller, E. R., Soliman, E. Z., Steigerwalt, S. P., Taliercio, J. J., Townsend, R. R., Weir, M. R., Wright, J. T., Xie, D., & Rahman, M.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Drawz, Paul E.
- ORCID
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2016-04
- Volume
- 11
- Issue
- 4
- Pages
- 642-652
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC4822674
- OpenAlex
- W2278752373
- Cited by
- 199
- References
- 47
- Citations by year
- 2026: 12 · 2025: 13 · 2024: 15 · 2023: 13 · 2022: 23 · 2021: 20 · 2020: 31 · 2019: 28 · 2018: 23 · 2017: 13 · 2016: 8
- FWCI
- 19.77
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Society of Nephrology
- National Institutes of Health (UL1TR000114, UL1TR000433, 5k23dk087919-05, UL1TR000424, UL1TR000003, UL1TR000439)
- National Institute of General Medical Sciences (P30GM103337)
- National Institute of Diabetes and Digestive and Kidney Diseases (K23-DK087919, K01DK092353, U01DK060990, DK 067390, R01DK067390, R01DK139225, U01DK060984, U01DK060902, U01DK060980, U01DK061022, U01DK060963, U01DK061021, U01DK061028)
- National Center for Research Resources (UL1RR024131, M01RR016500, UL1RR029879)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Keywords
- masked hypertension, nocturnal blood pressure, chronic kidney disease, white coat hypertension, sustained hypertension, estimated glomerular filtration rate, proteinuria, left ventricular mass, pulse wave velocity, ambulatory blood pressure monitoring, hypertension control, Chronic Renal Insufficiency Cohort Study, cardiovascular risk stratification, cardiovascular risk reclassification
- MeSH terms
- Aged, Cardiovascular Diseases, Cross-Sectional Studies, Female, Humans, Kidney Diseases, Male, Middle Aged, Cohort Studies, Prevalence, Renal Insufficiency, Chronic, Masked Hypertension
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.